{
  "Symbol": "VTRS",
  "AssetType": "Common Stock",
  "Name": "Viatris Inc",
  "Description": "Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.",
  "CIK": "1792044",
  "Exchange": "NASDAQ",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "PHARMACEUTICAL PREPARATIONS",
  "Address": "235 EAST 42ND STREET, NEW YORK, NY, US",
  "OfficialSite": "https://www.viatris.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "9036234000",
  "EBITDA": "4483200000",
  "PERatio": "None",
  "PEGRatio": "0.127",
  "BookValue": "15.61",
  "DividendPerShare": "0.48",
  "DividendYield": "0.0634",
  "EPS": "-0.53",
  "RevenuePerShareTTM": "12.35",
  "ProfitMargin": "-0.043",
  "OperatingMarginTTM": "0.128",
  "ReturnOnAssetsTTM": "0.0249",
  "ReturnOnEquityTTM": "-0.0324",
  "RevenueTTM": "14739300000",
  "GrossProfitTTM": "6138400000",
  "DilutedEPSTTM": "-0.53",
  "QuarterlyEarningsGrowthYOY": "-0.706",
  "QuarterlyRevenueGrowthYOY": "-0.081",
  "AnalystTargetPrice": "11.75",
  "AnalystRatingStrongBuy": "1",
  "AnalystRatingBuy": "2",
  "AnalystRatingHold": "5",
  "AnalystRatingSell": "0",
  "AnalystRatingStrongSell": "1",
  "TrailingPE": "-",
  "ForwardPE": "3.516",
  "PriceToSalesRatioTTM": "0.613",
  "PriceToBookRatio": "0.485",
  "EVToRevenue": "1.51",
  "EVToEBITDA": "7.89",
  "Beta": "0.908",
  "52WeekHigh": "13.38",
  "52WeekLow": "6.85",
  "50DayMovingAverage": "9.26",
  "200DayMovingAverage": "11.21",
  "SharesOutstanding": "1193690000",
  "DividendDate": "2025-03-18",
  "ExDividendDate": "2025-03-10",
  "Last Updated": "2025-04-23 14:46:05",
  "Price_Day_1": 7.69,
  "Price_Day_2": 7.57,
  "Price_Day_3": 7.56,
  "Price_Day_4": 7.39,
  "Price_Day_5": 7.48,
  "Price_Day_6": 7.63,
  "Price_Day_7": 7.54,
  "Income_totalRevenue_Q1": "3528100000",
  "Income_grossProfit_Q1": "1215000000",
  "Income_netIncome_Q1": "-516500000",
  "Income_totalRevenue_Q2": "3738000000",
  "Income_grossProfit_Q2": "1459200000",
  "Income_netIncome_Q2": "94800000",
  "Income_totalRevenue_Q3": "3796600000",
  "Income_grossProfit_Q3": "1493100000",
  "Income_netIncome_Q3": "-326400000",
  "Income_totalRevenue_Q4": "3663400000",
  "Income_grossProfit_Q4": "1504000000",
  "Income_netIncome_Q4": "113900000",
  "Balance_totalAssets_Q1": "41500900000",
  "Balance_totalLiabilities_Q1": "22865400000",
  "Balance_totalShareholderEquity_Q1": "18635500000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "734800000",
  "Balance_totalAssets_Q2": "44754100000",
  "Balance_totalLiabilities_Q2": "24961700000",
  "Balance_totalShareholderEquity_Q2": "19792400000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "1878700000",
  "Balance_totalAssets_Q3": "45330000000",
  "Balance_totalLiabilities_Q3": "25810000000",
  "Balance_totalShareholderEquity_Q3": "19520000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "917200000",
  "Balance_totalAssets_Q4": "47343700000",
  "Balance_totalLiabilities_Q4": "27329400000",
  "Balance_totalShareholderEquity_Q4": "20014300000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "1014600000",
  "Debt to Equity Ratio": 1.23,
  "Is Complete": true
}